Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A CXCR4-Targeted Dual-Acting Nanoconjugate Combines Protein-Toxin and Small-Molecule Warheads for Synergistic Cytotoxicity.

Created on 18 Nov 2026

Authors

Julian I Mendoza, Ariana Rueda, Gemma Quijada, Eric Volta-Durán, Esther Vazquez, Ramon Mangues, Antonio Villaverde, Ugutz Unzueta

Published in

Bioconjugate chemistry. Volume 37. Issue 11. Pages 2200-2209. Nov 18, 2026.

Abstract

Self-assembling multivalent protein nanoparticles with an architecture based on His-metal coordination and specific binding to cancer stem cells have emerged as promising tools for the selective delivery of microbial toxins in oncology, reaching precise cytotoxic effects. The incorporation of small-molecule drugs aimed at improving drug potency has so far been limited by the loss of stability and especially the loss of selectivity of the final products. Here, we have explored a site-specific conjugation method based on the Staphylococcus aureus sortase A, by which a CXCR4-targeted, engineered form of the diphtheria-toxin-derived protein warhead has been covalently enriched with the anti-tumoral agent monomethyl auristatin E (MMAE). The resulting dual-acting nanoscale conjugate exhibits enhanced cytotoxicity over CXCR4+ cells without compromising selectivity in the intracellular delivery process. Interestingly, the combination of the microbial toxin and MMAE, empowered by the multivalent display of the CXCR4-ligand T22, shows significant synergistic cytotoxicity over the target cells. Therefore, the suggested strategy allows not only the design of dual-acting targeted nanoconjugates that combine protein-toxin and small-molecule warheads in precise stoichiometric ratios but also the enhancement of their cytotoxic effects by allowing a synergistic action.

PMID:
43046836
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement